Deaths of two Chinese children receiving CRISPR therapy spark safety debate
read at Endpoints ↗RegulatoryNegative
Two children in China died after receiving experimental CRISPR-based gene therapies, according to a recent report.
The fatalities have unsettled researchers in the United States who are developing similar viral-based CRISPR medicines, prompting renewed scrutiny of the delivery method.
The cases have revived a long-standing debate over the safety of using viruses to carry CRISPR components, highlighting the need for stricter oversight before broader clinical use.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “China deaths reignite debate about using viruses to deliver CRISPR therapies”
read at Endpoints ↗85 words · retrieved Sep 2
comments(0)
5-min edit window · permanent after that